Sonata Capital Group’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$966K Buy
38,355
+213
+0.6% +$5.37K 0.31% 62
2026
Q1
$964K Buy
38,142
+4,387
+13% +$112K 0.36% 58
2025
Q4
$862K Buy
33,755
+5,906
+21% +$151K 0.31% 60
2025
Q3
$713K Buy
27,849
+15,849
+132% +$402K 0.26% 63
2025
Q2
$303K Buy
+12,000
New +$298K 0.12% 92

Other funds holding IBDX

Sonata Capital Group's IBDX Position: Q2 2026 in Review

Sonata Capital Group increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 0.56% in Q2 2026, buying an estimated $5.37K and bringing the position to 38,355 shares worth $966K. The position accounts for 0.31% of the portfolio, ranked #62.

Sonata Capital Group first reported a position in IBDX in Q2 2025 and has held it in 5 quarters since. 109 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Sonata Capital Group held 38,355 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $966K as of Q2 2026.
  • Sonata Capital Group bought 213 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $5.37K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.31% of Sonata Capital Group's portfolio in Q2 2026, its #62 holding.
  • Sonata Capital Group first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q2 2025 and has held it in 5 quarters since.
  • 109 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Sonata Capital Group's 13F filing for Q2 2026, filed 24 Jul 2026.